Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Arthritis and Rheumatism
|
June 30, 2005
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
Johan Askling, C Michael Fored, Lena Brandt, et al.
Annals of the Rheumatic Diseases
|
January 31, 2007
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
Johan Askling, C Michael Fored, Lena Brandt, et al.
Arthritis and Rheumatism
|
October 31, 2009
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Johan Askling, Ronald F van Vollenhoven, Fredrik Granath, et al.
Annals of the Rheumatic Diseases
|
March 16, 2007
Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper
Margreet Kloppenburg, Tanja Stamm, Iain Watt, et al.
Rheumatology (Oxford, England)
|
November 19, 2010
Ten years with biologics: to whom do data on effectiveness and safety apply?
Julia F Simard, Elizabeth V Arkema, Anders Sundström, et al.
Arthritis and Rheumatism
|
May 1, 2009
Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study
Jolanda Cibere, Hongbin Zhang, Patrick Garnero, et al.
Plos One
|
April 25, 2013
Associations between APOE genotypes and disease susceptibility, joint damage and lipid levels in patients with rheumatoid arthritis
Marthe T Maehlen, Sella A Provan, Diederik P C de Rooy, et al.
Annals of the Rheumatic Diseases
|
August 9, 2011
Delays in assessment of patients with rheumatoid arthritis: variations across Europe
Karim Raza, Rebecca Stack, Kanta Kumar, et al.
Arthritis Research & Therapy
|
June 3, 2014
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis
Rachel Knevel, Diederik P C de Rooy, Tore Saxne, et al.
Annals of the Rheumatic Diseases
|
October 9, 2012
Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis
Diederik P C de Rooy, Nataliya G Yeremenko, Anthony Gerard Wilson, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Arthritis and Rheumatism
|
June 30, 2005
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
Johan Askling, C Michael Fored, Lena Brandt, et al.
Annals of the Rheumatic Diseases
|
January 31, 2007
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
Johan Askling, C Michael Fored, Lena Brandt, et al.
Arthritis and Rheumatism
|
October 31, 2009
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Johan Askling, Ronald F van Vollenhoven, Fredrik Granath, et al.
Annals of the Rheumatic Diseases
|
March 16, 2007
Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper
Margreet Kloppenburg, Tanja Stamm, Iain Watt, et al.
Rheumatology (Oxford, England)
|
November 19, 2010
Ten years with biologics: to whom do data on effectiveness and safety apply?
Julia F Simard, Elizabeth V Arkema, Anders Sundström, et al.
Arthritis and Rheumatism
|
May 1, 2009
Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study
Jolanda Cibere, Hongbin Zhang, Patrick Garnero, et al.
Plos One
|
April 25, 2013
Associations between APOE genotypes and disease susceptibility, joint damage and lipid levels in patients with rheumatoid arthritis
Marthe T Maehlen, Sella A Provan, Diederik P C de Rooy, et al.
Annals of the Rheumatic Diseases
|
August 9, 2011
Delays in assessment of patients with rheumatoid arthritis: variations across Europe
Karim Raza, Rebecca Stack, Kanta Kumar, et al.
Arthritis Research & Therapy
|
June 3, 2014
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis
Rachel Knevel, Diederik P C de Rooy, Tore Saxne, et al.
Annals of the Rheumatic Diseases
|
October 9, 2012
Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis
Diederik P C de Rooy, Nataliya G Yeremenko, Anthony Gerard Wilson, et al.
Page
of 9